Prodesse’s ProParaflu+ Assay Cleared for US Marketing by FDA
Gen-Probe Inc has announced that the FDA has cleared for marketing Prodesse’s ProParaflu+ assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.
Read More